Clinical Trial

PROton Therapy for Post Surgical Treatment of GYNecologic Cancer

Study acronym: PROPS GYN
Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This is a single institution, multi-center, Phase II, single-arm study, using Whole Pelvis (WP) Pencil Beam Scanning Proton Radiation (PBS PRT) in the post-surgical, adjuvant setting for definitive treatment of gynecologic cancers. The purpose of this study is to estimate rate of acute clinician-reported gastrointestinal (GI) toxicity using WP PBS PRT in the definitive treatment of gynecologic cancers in the post-surgical, adjuvant setting.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2026-05 -> 2026-11 2026-06-11
minor Completion pushed: 2026-11 -> 2026-12 2026-06-11
Trial Details
NCT Number NCT05758688
Lead Sponsor Abramson Cancer Center at Penn Medicine
Conditions Cervical Cancer, Uterine Cancer, Endometrial Cancer
Enrollment 25 participants
Start Date 2023-11-06
Primary Completion 2026-11 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2026-06-10